Barriers to the treatment of childhood tuberculous infection and tuberculosis disease: a qualitative study

Int J Tuberc Lung Dis. 2017 Feb 1;21(2):154-160. doi: 10.5588/ijtld.16.0624.

Abstract

Setting: In 2012, Peru's National TB Program (NTP) reported approximately 2400 incident cases of tuberculosis (TB) disease in children aged <15 years. Peru's TB burden is concentrated in the Lima metropolitan area, particularly in poor districts such as El Agustino and La Victoria, where this study was conducted.

Objective: To identify barriers to the treatment of childhood tuberculous infection and TB disease in Lima from the perspective of front-line providers and patients' families.

Design: We conducted 10 semi-structured focus groups with 53 purposefully sampled primary care providers, community health workers, and parents/guardians of pediatric TB patients. We also completed nine in-depth interviews with National TB Program administrators and pulmonologists specializing in TB. Two authors performed inductive thematic analysis and identified emerging themes.

Results: Four main treatment barriers emerged from the data: 1) dosing errors, 2) time- and labor-intensive preparation and administration of medications, 3) provider concern that isoniazid preventive therapy (IPT) generates isoniazid resistance, and 4) poor adherence to IPT.

Conclusion: Our findings highlight the urgent need for child-friendly formulations, provider and parent/guardian education about IPT, and strategies to promote adherence to IPT, including support and supervision by health workers and/or regimens with fewer doses.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adolescent
  • Antitubercular Agents / administration & dosage*
  • Child
  • Child, Preschool
  • Community Health Workers
  • Drug Resistance, Bacterial
  • Female
  • Focus Groups
  • Humans
  • Isoniazid / administration & dosage*
  • Male
  • Medication Adherence*
  • Medication Errors
  • National Health Programs
  • Parents
  • Peru
  • Primary Health Care
  • Tuberculosis / drug therapy*

Substances

  • Antitubercular Agents
  • Isoniazid